End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9,890 KRW | +2.38% | -1.49% | +16.35% |
03-25 | Sihuan Pharmaceutical's RF Device Wins Registration Approval in China | MT |
2023 | SULLIVAN WILL DISCUSS EFFORTS TO REIN IN 'EXTREMIST SETTLER VIOL… | RE |
Sales 2023 | 42.52B 30.91M 2.48B | Sales 2024 * | 61.05B 44.38M 3.55B | Capitalization | 571B 415M 33.24B |
---|---|---|---|---|---|
Net income 2023 | 21B 15.27M 1.22B | Net income 2024 * | 28B 20.36M 1.63B | EV / Sales 2023 | 11.5 x |
Net cash position 2023 * | 50.98B 37.06M 2.97B | Net cash position 2024 * | 73.08B 53.13M 4.25B | EV / Sales 2024 * | 8.16 x |
P/E ratio 2023 |
23
x | P/E ratio 2024 * |
20.3
x | Employees | 54 |
Yield 2023 * |
0.1% | Yield 2024 * |
0.15% | Free-Float | 61.92% |
1 day | +2.38% | ||
1 week | -1.49% | ||
Current month | -8.93% | ||
1 month | -4.44% | ||
3 months | +23.47% | ||
6 months | +57.48% | ||
Current year | +16.35% |
Managers | Title | Age | Since |
---|---|---|---|
Sang-Jin Lee
CEO | Chief Executive Officer | 55 | - |
Jong-Ju Ra
CTO | Chief Tech/Sci/R&D Officer | 55 | - |
Seong-Jong Jo
AUD | Comptroller/Controller/Auditor | 66 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yong-Seok Park
BRD | Director/Board Member | 65 | - |
Sang-Jin Lee
CEO | Chief Executive Officer | 55 | - |
Dong-Seok Gwak
BRD | Director/Board Member | 55 | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 9,890 | +2.38% | 1,066,431 |
25/04/24 | 9,660 | -3.59% | 1,650,307 |
24/04/24 | 10,020 | -0.60% | 1,069,723 |
23/04/24 | 10,080 | +3.17% | 1,642,053 |
22/04/24 | 9,770 | -2.69% | 1,665,358 |
End-of-day quote Korea S.E., April 25, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.35% | 415M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- A335890 Stock